|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> GDC-0068>> Market Analysis Reports |
Market Analysis Reports of GDC-0068 |
|
Global Market Report of GDC-0068 (CAS 1001264-89-6) December 2024 Breast Cancer: KOL Insight [2018] ... (BYL 719; Novartis) taselisib (GDC 0032; Roche) ipatasertib (GDC 0068; RG 7440; Roche) entinostat ... Prostate Cancer - Newer Antiandrogens & Emerging Therapies Targeting a “Watchful Waiting” and Resistance Population Xtandi – Replacing competitor from Zytiga to Casodex (Bicalutamide) for a bigger pie in Prostate cancer & Finding its niche in crowded BC market Xtandi + Zytiga vs. ARN-509 + Zytiga - Who will win the race? Rising star Anti Androgens – Third generation ... Prostate Cancer [2017] How will established and emerging agents reshape the prostate cancer treatment landscape? A multitude of novel therapies have been approved for prostate cancer over the past ten years, but what does the future hold? Key opinion leaders (KOLs) are excited ... |